New York, NYNCT05538286Now EnrollingIRB Ready

Transcranial Ultrasound With Sonolucent Cranioplasty Clinical Trial in New York, NY

Access cutting-edge transcranial ultrasound with sonolucent cranioplasty treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by Icahn School of Medicine at Mount Sinai

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access transcranial ultrasound with sonolucent cranioplasty specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related transcranial ultrasound with sonolucent cranioplasty treatment provided free

Apply for This New York Location

Check if you qualify for this transcranial ultrasound with sonolucent cranioplasty clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Transcranial Ultrasound With Sonolucent Cranioplasty Study in New York

Postoperative rebleeding is a major limitation of surgical evacuation for intracerebral hemorrhage (ICH). While computed tomography (CT) is the standard of care for postoperative hematoma cavity monitoring, CT requires significant physical and financial costs. Studies have demonstrated varying degrees of efficacy when using transcranial ultrasound to measure ICH volume. Recently, synthetic implants for cranioplasty have been shown to be safe and sonolucent. This study aims to evaluate the ability of transcranial ultrasound with sonolucent cranioplasty (TUSC) to detect and quantify bleeding in postoperative ICH patients.

Sponsor: Icahn School of Medicine at Mount Sinai

Who Can Participate

Inclusion Criteria

Presence of spontaneous supratentorial ICH ≥20 mL
Age ≥18 years
National Institute of Health Stroke Scale (NIHSS) score ≥6
GCS score 5-15 at presentation
Undergoing minimally invasive intracerebral hemorrhage evacuation with sonolucent cranioplasty or hemicraniectomy with sonolucent cranioplasty

Exclusion Criteria

Secondary cause for the ICH, such as an underlying vascular malformation (cavernous malformation, arteriovenous malformation, etc.), aneurysm, neoplasm, hemorrhagic transformation of an underlying ischemic infarct; or venous infarct
History of osteomyelitis
History of skull neoplasm
History of comminuted skull fractures
Infratentorial hemorrhage
Midbrain extension/involvement
Coagulopathy defined as INR \> 1.4, elevated aPTT, or concurrent use of direct oral anticoagulants or low molecular weight heparin at ICH onset; known hereditary or acquired hemorrhagic diathesis; coagulation factor deficiency; platelet count \< 100x103cells/mm3, or known platelet dysfunction
Inability to obtain consent from patient or appropriate surrogate (for patients without capacity)
Evidence of active infection indicated by fever ≥ 100.7F and/or open draining wound at the time of enrolment
Any comorbid disease or condition expected to compromise survival or ability to complete follow-up assessments through 1 year
Based on investigator's judgment, the patient does not have the necessary mental capacity to participate or is unwilling to comply with the protocol follow-up appointment schedule
Active drug or alcohol abuse that, in the opinion of the site investigator, would interfere with adherence to study enrolments
Pre-existing DNR/DNI status

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT05538286) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Transcranial Ultrasound With Sonolucent Cranioplasty Treatment Options in New York, NY

If you're searching for transcranial ultrasound with sonolucent cranioplasty treatment options in New York, NY, this clinical trial (NCT05538286) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced transcranial ultrasound with sonolucent cranioplasty specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all transcranial ultrasound with sonolucent cranioplasty clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in New York, NY

See all rheumatoid arthritis clinical trials recruiting in New York — not just this study.

Browse Rheumatoid Arthritis Trials in New York →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsUlcerative Colitis TrialsAnkylosing Spondylitis TrialsAll Conditions →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY